| 臺大學術典藏 |
2018-09-10T15:32:30Z |
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients
|
Wu, Shang-Gin;Liu, Yi-Nan;Tsai, Meng-Feng;Chang, Yih-Leong;Yu, Chong-Jen;Yang, Pan-Chyr;Yang, James Chih-Hsin;Wen, Yueh-Feng;Shih, Jin-Yuan; Wu, S-G. and Liu, Y.-N. and Tsai, M.-F. and Chang, Y.-L. and Yu, C.-J. and Yang, P.-C. and Yang, J.C.-H. and Wen, Y.-F. and Shih, J.-Y.; 楊志新;張逸良;楊泮池;余忠仁;溫岳峰;吳尚俊;施金元; YIH-LEONG CHANG; Tung, Li-Chen; Wu, Shang-Gin; Liu, Yi-Nan; Lin, Chin-Kai; Chong-Jen Yu; Hsieh, Ching-Lin; Tsai, Meng-Feng; JIN-YUAN SHIH; Chang, Yih-Leong; Chen, Ching-Chi; Huang, Chin-Tsan; Yu, Chong-Jen; Wang, Chun-Hou; Yang, Pan-Chyr; Yang, James Chih-Hsin; Wen, Yueh-Feng; Shih, Jin-Yuan; ??M??; 楊志新; 張逸良; 楊泮池; 余忠仁; 溫岳峰; 吳尚俊; 施金元 |
